Cargando…

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics

In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission...

Descripción completa

Detalles Bibliográficos
Autores principales: Volz, Erik M., Ndembi, Nicaise, Nowak, Rebecca, Kijak, Gustavo H., Idoko, John, Dakum, Patrick, Royal, Walter, Baral, Stefan, Dybul, Mark, Blattner, William A., Charurat, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534066/
https://www.ncbi.nlm.nih.gov/pubmed/28775893
http://dx.doi.org/10.1093/ve/vex014
_version_ 1783253718316089344
author Volz, Erik M.
Ndembi, Nicaise
Nowak, Rebecca
Kijak, Gustavo H.
Idoko, John
Dakum, Patrick
Royal, Walter
Baral, Stefan
Dybul, Mark
Blattner, William A.
Charurat, Man
author_facet Volz, Erik M.
Ndembi, Nicaise
Nowak, Rebecca
Kijak, Gustavo H.
Idoko, John
Dakum, Patrick
Royal, Walter
Baral, Stefan
Dybul, Mark
Blattner, William A.
Charurat, Man
author_sort Volz, Erik M.
collection PubMed
description In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission patterns between men who have sex with men (MSM) and a representative sample of newly enrolled treatment naive HIV clients without clearly recorded HIV acquisition risks. We develop a realistic dynamical infectious disease model which was fitted to time-scaled phylogenies for subtypes G and CRF02_AG using a structured-coalescent approach. We compare the infectious disease model and structured coalescent to commonly used genetic clustering methods. We estimate HIV incidence among MSM of 7.9% (95%CI, 7.0–10.4) per susceptible person-year, and the population attributable fraction of HIV transmissions from MSM to reproductive age females to be 9.1% (95%CI, 3.8–18.6), and from the reproductive age women to MSM as 0.2% (95%CI, 0.06–0.3). Applying these parameter estimates to evaluate a test-and-treat HIV strategy that target MSM reduces the total HIV infections averted by half with a 2.5-fold saving. These results suggest the importance of addressing the HIV treatment needs of MSM in addition to cost-effectiveness of specific scale-up of treatment for MSM in the context of the mixed HIV epidemic observed in Nigeria.
format Online
Article
Text
id pubmed-5534066
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-55340662017-08-03 Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics Volz, Erik M. Ndembi, Nicaise Nowak, Rebecca Kijak, Gustavo H. Idoko, John Dakum, Patrick Royal, Walter Baral, Stefan Dybul, Mark Blattner, William A. Charurat, Man Virus Evol Research Article In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission patterns between men who have sex with men (MSM) and a representative sample of newly enrolled treatment naive HIV clients without clearly recorded HIV acquisition risks. We develop a realistic dynamical infectious disease model which was fitted to time-scaled phylogenies for subtypes G and CRF02_AG using a structured-coalescent approach. We compare the infectious disease model and structured coalescent to commonly used genetic clustering methods. We estimate HIV incidence among MSM of 7.9% (95%CI, 7.0–10.4) per susceptible person-year, and the population attributable fraction of HIV transmissions from MSM to reproductive age females to be 9.1% (95%CI, 3.8–18.6), and from the reproductive age women to MSM as 0.2% (95%CI, 0.06–0.3). Applying these parameter estimates to evaluate a test-and-treat HIV strategy that target MSM reduces the total HIV infections averted by half with a 2.5-fold saving. These results suggest the importance of addressing the HIV treatment needs of MSM in addition to cost-effectiveness of specific scale-up of treatment for MSM in the context of the mixed HIV epidemic observed in Nigeria. Oxford University Press 2017-07-28 /pmc/articles/PMC5534066/ /pubmed/28775893 http://dx.doi.org/10.1093/ve/vex014 Text en © The Author 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Volz, Erik M.
Ndembi, Nicaise
Nowak, Rebecca
Kijak, Gustavo H.
Idoko, John
Dakum, Patrick
Royal, Walter
Baral, Stefan
Dybul, Mark
Blattner, William A.
Charurat, Man
Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title_full Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title_fullStr Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title_full_unstemmed Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title_short Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
title_sort phylodynamic analysis to inform prevention efforts in mixed hiv epidemics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534066/
https://www.ncbi.nlm.nih.gov/pubmed/28775893
http://dx.doi.org/10.1093/ve/vex014
work_keys_str_mv AT volzerikm phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT ndembinicaise phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT nowakrebecca phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT kijakgustavoh phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT idokojohn phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT dakumpatrick phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT royalwalter phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT baralstefan phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT dybulmark phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT blattnerwilliama phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics
AT charuratman phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics